Navigation Links
Ukrainian President Yushchenko: Pharmaceuticals 'Very Important'
Date:9/30/2008

- MaxWell Biocorporation Wins Presidential Support for Faster Registration

of Modern Medicines in Ukraine -

WASHINGTON, Sept. 30 /PRNewswire/ -- Dr. Kenneth Alibek, President and CEO of MaxWell Biocorporation, LLC, and Dr. Peter M. Leitner, President of MaxWell USA, LLC, participated today in a presidential breakfast to honor Ukrainian President Victor Yushchenko.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080624/NETU078LOGO )

The breakfast was hosted by the U.S.-Ukraine Business Council (USUBC). Nearly 100 senior business leaders, academics, and diplomats attended this invitation-only event, including three former United States ambassadors to Ukraine and the current US Ambassador to Kyiv William Taylor.

President Yushchenko discussed the current political and economic situation in Ukraine. The President repeated his strong support for Ukraine's further integration into the Euro-Atlantic community as shown by the recent events in Georgia, spoke about Ukraine's business environment, thanked the U.S. companies for their investments in Ukraine, and urged American investors to participate in even more projects in Ukraine.

Asking the first question, Dr. Alibek asked the Ukrainian President about prospects for ensuring timely registration and licensing procedures for foreign pharmaceutical companies with established production facilities in Ukraine, in order to expedite access to the latest medicines for the people of Ukraine. Companies are experiencing unnecessary and costly delays in this area, Dr. Alibek noted.

President Yushchenko stated that it is very important for Ukraine to have the latest and most effective pharmaceuticals. The Ukrainian President promised he would monitor this situation, and suggested to Dr. Alibek that he work closely with Mr. Yushchenko's staff to resolve this issue.

Later the same day, President Yushchenko met with President Bush at the White House, spoke at the National Press Club, and laid a wreath at the monument to famous Ukrainian poet Taras Shevchenko in Washington, DC.

About MaxWell

MaxWell Biocorporation (http://www.max-well.com) is a U.S.-based, privately-held international medical and pharmaceutical company with wholly owned subsidiaries and affiliates in the United States and Ukraine dedicated to increasing life expectancy and improving the quality of life of people in Ukraine and other underserved emerging healthcare markets in the former Soviet Union. MaxWell targets oncological, cardiological, chronic infectious and autoimmune disorders and diseases through the development, production, and introduction into clinical practice of sophisticated, high quality, and affordable off-patent generic biopharmaceutical and chemopharmaceutical medicines and the latest diagnostic and therapeutic methods. MaxWell = "Maximum Wellness."

"We Help You Live Longer"

Contact:

Alex Meerovich

A.Meerovich@max-well.com

202-454-3403 Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Kenneth Alibek https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=78826 Peter Leitner https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=78827


'/>"/>
SOURCE MaxWell Biocorporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. KGI Names Kerry Howell Vice President for Advancement
2. Vical Names Andrew de Guttadauro Vice President, Corporate Development
3. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
4. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
5. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
6. Prestwick Pharmaceuticals, Inc. Continues to Build Management Team With Appointment of Martin Stogniew, Ph.D. as Executive Vice President, Chief Technology Officer
7. CryoLife Names Philip Theodore as Vice President, General Counsel
8. Dr. Keith Wilson Named President and Chief Scientific Officer of Takeda San Diego
9. AGI Dermatics President to be Keynote Speaker at the 11th Annual Sunscreen Symposium
10. Alba Therapeutics Appoints Dr. Betsy Van Parijs as Its Senior Vice President, Clinical Development and Medical Affairs
11. Premier Research Appoints Melissa Jones as Vice President, International Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... ... September 22, 2017 , ... ... is now being assessed in clinical trials in the United States. (clinicaltrials.gov : ... your nurse or physician or find your nearest participating clinic here https://factor-therapeutics.com/clinical-trials/ ...
(Date:9/21/2017)... , ... September 21, 2017 , ... Dr. Greg Leyer, ... Vegas, NV on September 27th. His presentation is at 12:10pm in the Probiotics Resource ... to present at SupplySide West and discuss how probiotics have shown impressive data in ...
(Date:9/21/2017)... ... September 21, 2017 , ... Colpitts Clinical has launched the ... includes new features that facilitate streamlined and compliant communication, file sharing and document ... forefront of medical advancements, they rely on efficiencies to help them address the ...
(Date:9/21/2017)... New Jersey (PRWEB) , ... September 21, 2017 ... ... highly-regulated pharmaceutical and clinical research sector professionals, has announced the addition of 5 ... Part 11 training - Compliance with Regulation 21 CFR Part 11 on ...
Breaking Biology Technology:
(Date:5/16/2017)... 16, 2017  Veratad Technologies, LLC ( www.veratad.com ), ... and identity verification solutions, announced today they will participate ... May 15 thru May 17, 2017, in ... Trade Center. Identity impacts the lives ... today,s quickly evolving digital world, defining identity is critical ...
(Date:4/18/2017)... a global expert in SoC-based imaging and computing solutions, has developed ... the company,s hybrid codec technology. A demonstration utilizing TeraFaces ® , ... showcased during the upcoming Medtec Japan at Tokyo Big Sight April ... Vegas Convention Center April 24-27. ... Click here for an image of the M820 ...
(Date:4/11/2017)... Research and Markets has announced the addition of the "Global ... ... at a CAGR of 30.37% during the period 2017-2021. ... based on an in-depth market analysis with inputs from industry experts. ... the coming years. The report also includes a discussion of the ...
Breaking Biology News(10 mins):